These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24204690)

  • 1. Cancer-predicting gene expression changes in colonic mucosa of Western diet fed Mlh1+/- mice.
    Pussila M; Sarantaus L; Dermadi Bebek D; Valo S; Reyhani N; Ollila S; Päivärinta E; Peltomäki P; Mutanen M; Nyström M
    PLoS One; 2013; 8(10):e76865. PubMed ID: 24204690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited cancer predisposition sensitizes colonic mucosa to address Western diet effects and putative cancer-predisposing changes on mouse proteome.
    Đermadi D; Valo S; Pussila M; Reyhani N; Sarantaus L; Lalowski M; Baumann M; Nyström M
    J Nutr Biochem; 2014 Nov; 25(11):1196-1206. PubMed ID: 25172634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mlh1 deficiency in normal mouse colon mucosa associates with chromosomally unstable colon cancer.
    Pussila M; Törönen P; Einarsdottir E; Katayama S; Krjutškov K; Holm L; Kere J; Peltomäki P; Mäkinen MJ; Linden J; Nyström M
    Carcinogenesis; 2018 May; 39(6):788-797. PubMed ID: 29701748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice.
    Morioka T; Miyoshi-Imamura T; Blyth BJ; Kaminishi M; Kokubo T; Nishimura M; Kito S; Tokairin Y; Tani S; Murakami-Murofushi K; Yoshimi N; Shimada Y; Kakinuma S
    Cancer Sci; 2015 Mar; 106(3):217-26. PubMed ID: 25529563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of MLH1 and MGMT genes in colon mucosa adjacent to implanted cancer in athymic mouse.
    Kuniyasu H; Sasaki T; Sasahira T; Chihara Y; Ohmori H
    J Exp Clin Cancer Res; 2004 Jun; 23(2):317-23. PubMed ID: 15354418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
    Alemayehu A; Sebova K; Fridrichova I
    Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.
    Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N
    Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas.
    Kaz A; Kim YH; Dzieciatkowski S; Lynch H; Watson P; Kay Washington M; Lin L; Grady WM
    Int J Cancer; 2007 May; 120(9):1922-9. PubMed ID: 17278092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
    van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H
    BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation.
    Bouzourene H; Hutter P; Losi L; Martin P; Benhattar J
    Fam Cancer; 2010 Jun; 9(2):167-72. PubMed ID: 19949877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency.
    Goel A; Xicola RM; Nguyen TP; Doyle BJ; Sohn VR; Bandipalliam P; Rozek LS; Reyes J; Cordero C; Balaguer F; Castells A; Jover R; Andreu M; Syngal S; Boland CR; Llor X
    Gastroenterology; 2010 May; 138(5):1854-62. PubMed ID: 20102720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.
    Crucianelli F; Tricarico R; Turchetti D; Gorelli G; Gensini F; Sestini R; Giunti L; Pedroni M; Ponz de Leon M; Civitelli S; Genuardi M
    Epigenetics; 2014 Oct; 9(10):1431-8. PubMed ID: 25437057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.
    Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A
    Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLH1 methylation screening is effective in identifying epimutation carriers.
    Pineda M; Mur P; Iniesta MD; Borràs E; Campos O; Vargas G; Iglesias S; Fernández A; Gruber SB; Lázaro C; Brunet J; Navarro M; Blanco I; Capellá G
    Eur J Hum Genet; 2012 Dec; 20(12):1256-64. PubMed ID: 22763379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
    Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
    Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry for annexin A10 can distinguish sporadic from Lynch syndrome-associated microsatellite-unstable colorectal carcinoma.
    Pai RK; Shadrach BL; Carver P; Heald B; Moline J; Church J; Kalady MF; Burke CA; Plesec TP; Lai KK; Gonzalo DH; Pai RK
    Am J Surg Pathol; 2014 Apr; 38(4):518-25. PubMed ID: 24625416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.
    Morak M; Schackert HK; Rahner N; Betz B; Ebert M; Walldorf C; Royer-Pokora B; Schulmann K; von Knebel-Doeberitz M; Dietmaier W; Keller G; Kerker B; Leitner G; Holinski-Feder E
    Eur J Hum Genet; 2008 Jul; 16(7):804-11. PubMed ID: 18301449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term folate supplementation in physiological doses has no effect on ESR1 and MLH1 methylation in colonic mucosa of individuals with adenoma.
    Al-Ghnaniem Abbadi R; Emery P; Pufulete M
    J Nutrigenet Nutrigenomics; 2012; 5(6):327-38. PubMed ID: 23328702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.